The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Increased Lipid Peroxidation in Patients with Pulmonary Hypertension
Abstract
Isoprostanes are chemically stable lipid peroxidation products of arachidonic acid, the quantification of which provides a novel approach to the assessment of oxidative stress in vivo. The main objective of this study was to quantify the urinary levels of isoprostaglandin F(2alpha) type III (iPF(2alpha)-III), an F(2)-isoprostane, in patients with pulmonary hypertension (PHT) in comparison with healthy controls. The secondary objective was to test whether baseline iPF(2alpha)-III levels correlate to the reversibility of pulmonary hypertension in response to inhaled NO challenge. Urinary iPF(2alpha)-III levels were measured by gas chromatography-mass spectrometry in 25 patients with PHT, 14 of whom were investigated for response to inhaled NO challenge. Urinary iPF(2alpha)-III levels in PHT patients (225 +/- 27 pmol/mmol creatinine) were 2.3 times as high as in controls (97 +/- 7 pmol/mmol creatinine, p < 0.001). The mean pulmonary arterial pressure variation and the pulmonary vascular resistance variation in response to inhaled NO were correlated to basal iPF(2alpha)-III levels. This study shows that oxidative stress is increased in patients with pulmonary hypertension. Furthermore, iPF(2alpha)-III levels inversely correlate to pulmonary vasoreactivity. These observations are consistent with the hypothesis that free radical generation is involved in PHT pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
PEPKEZABA, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92033-x · Cited by 1,055
Cited by
Oxidative Stress in Severe Pulmonary Hypertension
Bowers, R., Cool, C., Murphy, R. C., Tuder, R. M., Hopken, M. W., Flores, S. C., & Voelkel, N. F. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-147oc · Cited by 366
Cracowski, J.-L., Durand, T., & Bessard, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02053-9 · Cited by 330
Self-citationApplication of ’omics technologies to biomarker discovery in inflammatory lung diseases
Wheelock, C. E., Goss, V. M., Balgoma, D., Nicholas, B., Brandsma, J., Skipp, P. J., Snowden, S., Burg, D., D'Amico, A., Horvath, I., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00078812 · Cited by 272
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Basu, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1956 · Cited by 268
Hypoxia Inducible-Factor1α Regulates the Metabolic Shift of Pulmonary Hypertensive Endothelial Cells
Fijalkowska, I., Xu, W., Comhair, S. A. A., Janocha, A. J., Mavrakis, L. A., Krishnamachary, B., Zhen, L., Mao, T., Richter, A., Erzurum, S. C., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090832 · Cited by 263
Metadata
- Authors
- CRACOWSKI, J.-L., CRACOWSKI, C., BESSARD, G., PEPIN, J.-L., BESSARD, J., SCHWEBEL, C., STANKE-LABESQUE, F., & PISON, C.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-15
- Volume
- 164
- Issue
- 6
- Pages
- 1038-1042
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2077859927
- Cited by
- 186
- References
- 1
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Lipid Peroxidation in Patients with Pulmonary Hypertension. https://app.cochat.ai/papers/10.1164/ajrccm.164.6.2104033
- The paper
- CRACOWSKI, J.-L., CRACOWSKI, C., BESSARD, G., PEPIN, J.-L., BESSARD, J., SCHWEBEL, C., STANKE-LABESQUE, F., & PISON, C. (2001). Increased Lipid Peroxidation in Patients with Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.164.6.2104033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.